JEREMY BRITT: Open Payments
NPI 1578911996 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,428 in 80 payments from 23 companies in 2025. Trend: 2023 $1,193 · 2024 $1,487 · 2025 $1,428
Food & beverage: $1,428
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 19 | $418 |
| GlaxoSmithKline, LLC. | 15 | $208 |
| Novo Nordisk Inc | 11 | $159 |
| Amgen Inc. | 5 | $74 |
| PFIZER INC. | 4 | $67 |
| Novartis Pharmaceuticals Corporation | 2 | $48 |
| Lilly USA, LLC | 3 | $47 |
| Phathom Pharmaceuticals, Inc. | 3 | $47 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
| Eisai Inc. | 2 | $40 |
Products named: AIRSUPRA, BREZTRI, TRELEGY ELLIPTA, SHINGRIX, Ozempic, Wegovy, NURTEC ODT, LEQVIO.
Industry payments across AZ — which companies pay providers there.
